Neervannan Seshadri

CIK 00018275841 companyIRVINE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001827584

Recent Transactions

33 trades

Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2026-03-05+27,310→ 27,310 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2026-03-05+17,161→ 17,161 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2026-03-04$76.67/sh−8,366→ 70,817 total
Gift
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-12-16−950→ 79,183 total
Gift
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-12-16+475→ 475 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-03-20$50.11/sh−2,435→ 79,682 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-03-19$47.40/sh−2,543→ 82,117 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-03-18$46.29/sh−2,605→ 84,660 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-03-15−8,148→ 16,296 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-03-15+21,264→ 87,265 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-03-15−8,019→ 24,060 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-03-15−5,097→ 5,097 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2025-03-05+30,628→ 30,628 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-03-05+20,089→ 20,089 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2024-03-18$30.60/sh−4,879→ 64,767 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2024-03-15−5,097→ 10,194 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2024-03-15−8,148→ 24,444 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2024-03-15+13,245→ 69,646 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2024-03-07+32,079→ 32,079 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2024-03-07+47,500→ 47,500 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-03-23$12.15/sh−390→ 54,696 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-03-22$12.64/sh−379→ 55,086 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-03-21$12.89/sh−372→ 55,465 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-03-20$12.61/sh−380→ 55,837 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-03-17$13.28/sh−360→ 56,217 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-03-16$13.43/sh−357→ 56,577 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2023-03-15−5,097→ 15,291 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-03-15+5,097→ 56,934 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2023-03-08+32,592→ 32,592 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2023-03-08+48,116→ 48,116 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2022-03-09+20,388→ 20,388 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2022-03-09+69,498→ 69,498 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2021-01-07+61,499→ 61,499 total

Companies

Tarsus Pharmaceuticals, Inc.
Chief Operating Officer
$TARS

Recent Filings

Address

C/O TARSUS PHARMACEUTICALS, INC. 15440 LAGUNA CANYON ROAD, SUITE 160

IRVINE, CA, 92618

View on SEC.gov